Several inhibitors have been designed for SphK1; French et al. evaluated a large number of non-lipid synthetic inhibitors of SphK1 and demonstrated that they induced apoptosis and cell cytotoxicity in many cancer cell lines, as well as in multidrug-resistant cell lines [63]. Here, SPHK1 is linked to cancer.